Glasdegib in Addition to Intensive or Non-Intensive Chemotherapy in Patients with Acute Myeloid Leukemia: Safety Analysis of Glasdegib 'On Target' Adverse Events

被引：5

作者：

Cortes, Jorge E. ^{[1
]}

Papayannidis, Cristina ^{[2
]}

Jamieson, Catriona ^{[3
,4
]}

Schiller, Gary J. ^{[5
]}

Candoni, Anna ^{[6
]}

Leber, Brian ^{[7
]}

Baldus, Claudia D. ^{[8
]}

Perez-Simon, Jose A. ^{[9
]}

Ma, Weidong Wendy ^{[10
]}

Gallo, Corrado ^{[10
]}

O'Connell, Ashleigh ^{[10
]}

Zeremski, Mirjana ^{[11
]}

Chan, Geoffrey ^{[12
]}

Sekeres, Mikkael A. ^{[13
]}

机构：

[1] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA

[2] Univ Bologna, Inst Hematol L&A Seragnoli, Dept Expt Diagnost & Specialty Med, Bologna, Italy

[3] Univ Calif San Diego, Sanford Stem Cell Clin Ctr, San Diego, CA 92103 USA

[4] Univ Calif San Diego, Moores Canc Ctr, San Diego, CA 92103 USA

[5] Ronald Regan Univ Calif Los Angeles Med Ctr, Santa Monica, CA USA

[6] Azienda Sanit Univ Integrata Udine, Div Hematol & Bone Marrow Transplantat, Udine, Italy

[7] Juravinski Hosp & Canc Ctr, Hamilton, ON, Canada

[8] Charite Univ Med Berlin, Hamatol & Onkol, Berlin, Germany

[9] Univ Seville, Inst Biomed Sevilla IBiS, Hosp Univ Virgen del Rocio CSIC CIBERONC, UGC Hematol, Seville, Spain

[10] Pfizer Inc, New York, NY USA

[11] Pfizer Canada Inc, Kirkland, PQ, Canada

[12] Pfizer Oncol, Collegeville, PA USA

[13] Cleveland Clin, Leukemia Program, Cleveland, OH 44106 USA

来源：

关键词：

D O I：

10.1182/blood-2018-99-110934

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

2732

引用

页数：4